Pages that link to "Q34471115"
Jump to navigation
Jump to search
The following pages link to ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia. (Q34471115):
Displaying 33 items.
- Asparaginase treatment side-effects may be due to genes with homopolymeric Asn codons (Review-Hypothesis) (Q26801165) (← links)
- ASPP [corrected] and cancer (Q28299046) (← links)
- Vorinostat induces apoptosis and differentiation in myeloid malignancies: genetic and molecular mechanisms (Q28484904) (← links)
- ASPP1/2 regulate p53-dependent death of retinal ganglion cells through PUMA and Fas/CD95 activation in vivo (Q28571503) (← links)
- Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region- containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma (Q30157007) (← links)
- Epigenetic signatures associated with different levels of differentiation potential in human stem cells (Q30885935) (← links)
- ASPP: a new family of oncogenes and tumour suppressor genes (Q31090644) (← links)
- iASPP is over-expressed in human non-small cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway (Q33782345) (← links)
- Frequent and simultaneous epigenetic inactivation of TP53 pathway genes in acute lymphoblastic leukemia (Q33840913) (← links)
- The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1 (Q34244270) (← links)
- iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. (Q34565058) (← links)
- LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome. (Q35082503) (← links)
- The effects of DNA methylation and histone deacetylase inhibitors on human papillomavirus early gene expression in cervical cancer, an in vitro and clinical study (Q35674823) (← links)
- Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies (Q35909637) (← links)
- Epigenetics: an emerging technology in the diagnosis and treatment of cancer (Q36555927) (← links)
- Poor prognosis in acute lymphoblastic leukemia may relate to promoter hypermethylation of cancer-related genes (Q36871702) (← links)
- Epigenetic regulation of miRNA genes in acute leukemia. (Q37965026) (← links)
- Restoring the tumour suppressive function of p53 as a parallel strategy in melanoma therapy. (Q38213115) (← links)
- Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia. (Q38327984) (← links)
- Regulation of hematopoietic stem cell integrity through p53 and its related factors. (Q38676677) (← links)
- MicroRNA124 regulate cell growth of prostate cancer cells by targeting iASPP. (Q38981127) (← links)
- Expression of myeloperoxidase in acute myeloid leukemia blasts mirrors the distinct DNA methylation pattern involving the downregulation of DNA methyltransferase DNMT3B. (Q39031283) (← links)
- Significance of Inactivated Genes in Leukemia: Pathogenesis and Prognosis (Q39350173) (← links)
- Downregulation of ASPP1 in gestational trophoblastic disease: correlation with hypermethylation, apoptotic activity and clinical outcome. (Q39628510) (← links)
- Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP. (Q39637300) (← links)
- BCR-ABL1-induced expression of HSPA8 promotes cell survival in chronic myeloid leukaemia (Q39974408) (← links)
- Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia (Q40200349) (← links)
- EGR-1/ASPP1 inter-regulatory loop promotes apoptosis by inhibiting cyto-protective autophagy (Q41084272) (← links)
- Epigenetic silencing of ASPP1 confers 5-FU resistance in clear cell renal cell carcinoma by preventing p53 activation. (Q47979679) (← links)
- Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance. (Q54300030) (← links)
- Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family. (Q54570256) (← links)
- Downregulation of DBC1 expression in acute lymphoblastic leukaemia is mediated by aberrant methylation of its promoter (Q79920520) (← links)
- ASPP1 deficiency promotes epithelial-mesenchymal transition, invasion and metastasis in colorectal cancer (Q91738783) (← links)